Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | KMO | O15229 | 1/20 | 0.56 |
| ▸ | AR | P10275 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.54 |
| ▸ | HTR3B | O95264 | 1/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11203977 | 1.00 | LMNA (1.00) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL10070687 | 1.00 | LMNA (1.00) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL13809379 | 1.00 | LMNA (1.00) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL254812 | 0.97 | LMNA (0.95) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL3948094 | 0.97 | LMNA (0.95) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL2555823 | 0.97 | LMNA (0.95) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL4408839 | 0.95 | LMNA (0.91) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| SCHEMBL184087 | 0.95 | LMNA (0.91) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| Hydrochloric Acid SCHEMBL9131024 | 0.95 | LMNA (0.91) | LMNAAKR1C3PKMTSHRCYP2C9 | |
| Ammonia Solution, Strong SCHEMBL4262260 | 0.95 | LMNA (0.91) | LMNAAKR1C3PKMTSHRCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3940806-B1 | METHOD OF MODIFYING THE STRUCTURE OF PEROVSKITE FILMS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2023-08-16 | — | — | EP | claimed |
| CN-116759632-A | Crown ether lithium salt compound and perovskite lithium battery thereof | 美能能源技术(苏州)有限公司 | 2023-09-15 | — | — | CN | disclosed |
| EP-3940806-B1 | METHOD OF MODIFYING THE STRUCTURE OF PEROVSKITE FILMS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-20210249714-A1 | Lithium Air Secondary Battery | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2021-08-12 | — | — | US | disclosed |
| US-11059995-B2 | Film forming composition | MERCK PATENT GMBH (DE) | 2021-07-13 | — | — | US | disclosed |
| US-20200377761-A1 | FILM FORMING COMPOSITION | MERCK PATENT GMBH (DE) | 2020-12-03 | — | — | US | disclosed |
| US-9257651-B2 | Organic electroluminescence element and method for manufacturing organic electroluminescence element | KONICA MINOLTA HOLDINGS, INC. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-20130087778-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENCE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130087778-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENCE ELEMENT | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-04-11 | — | — | US | disclosed |
| WO-2012040204-A2 | CYTOSOLIC FLUORESCENT ION INDICATORS | ASANTE RESEARCH, LLC (US) | 2012-03-29 | — | — | WO | disclosed |
| US-7541462-B2 | Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20080139806-A1 | TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.. | 2008-06-12 | — | — | US | disclosed |
| US-7385058-B1 | Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| EP-0171401-A1 | PLATINUM AND CROWN ETHER COMPLEXES WITH ANTINEOPLASTIC ACTIVITY AND DRUG CONTAINING THEM | Medac Gesellschaft für klinische Spezialpräparate mbH (DE) | 1986-02-19 | — | — | EP | disclosed |
| WO-1985003078-A1 | PLATINUM AND CROWN ETHER COMPLEXES WITH ANTINEOPLASTIC ACTIVITY AND DRUG CONTAINING THEM | MEDAC GESELLSCHAFT FÜR KLINISCHE SPEZIALPRÄPARATE (DE) | 1985-07-18 | — | — | WO | disclosed |
| EP-0054668-B1 | PROCESS FOR THE PREPARATION OF IODO-ORGANYL-ALKOXY SILANES | Degussa Aktiengesellschaft (DE) | 1985-01-16 | — | — | EP | disclosed |
| US-4362885-A | Process for the manufacture of (iodoorganyl)alkoxysilanes | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1982-12-07 | — | — | US | disclosed |
| EP-0054668-A2 | Process for the preparation of iodo-organyl-alkoxy silanes | Degussa Aktiengesellschaft (DE) | 1982-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139806-A1 | TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION | ABL1, AOC1, NPPA | LMNA 3290/4885AKR1C3 2899/4885PKM 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.